Advances and challenges in the management of essential thrombocythemia.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 3, p. 142, doi. 10.1177/2040620715580068
- By:
- Publication type:
- Article
Works matching IS 20406207 AND DT 2015 AND VI 6 AND IP 3
Results: 5
1
2
Inhibition of bromodomain and extraterminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 3, p. 128, doi. 10.1177/2040620715576662
- By:
- Publication type:
- Article
3
Daratumumab and its potential in the treatment of multiple myeloma: overview of the preclinical and clinical development.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 3, p. 120, doi. 10.1177/2040620715572295
- By:
- Publication type:
- Article
4
Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 3, p. 103, doi. 10.1177/2040620715577614
- By:
- Publication type:
- Article
5
Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 3, p. 97, doi. 10.1177/2040620715571076
- By:
- Publication type:
- Article